resveratrol has been researched along with Endotoxin Shock in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, CY; Kuang, L; Li, T; Liu, LM; Wu, Y; Yang, GM; Zang, JT; Zhang, ZS; Zhao, HL; Zheng, DY; Zhu, Y | 1 |
Esparza, I; Gamazo, C; González-Navarro, CJ; Irache, JM; Larraneta, E; Penalva, R | 1 |
2 other study(ies) available for resveratrol and Endotoxin Shock
Article | Year |
---|---|
Role of resveratrol in protecting vasodilatation function in septic shock rats and its mechanism.
Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Down-Regulation; Female; Hemodynamics; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Liver; Male; Microcirculation; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; rac1 GTP-Binding Protein; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Shock, Septic; Splanchnic Circulation; Up-Regulation; Vasodilation | 2019 |
Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Availability; Disease Models, Animal; Drug Carriers; Female; Humans; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Rats; Rats, Wistar; Resveratrol; Shock, Septic; Stilbenes; Tumor Necrosis Factor-alpha; Zein | 2015 |